Firms
Theme

FRD

Friedman Industries Inc. · NASDAQ

News

3 latest

Zacks Investment Research

Friedman Surges More Than 127% in 6 Months: What's Driving the Stock?

Friedman Industries (FRD) has gained 127.4% over the past six months, significantly outperforming its industry and the S&P 500. The company's strong performance is driven by record sales volumes, improved pricing, successful Century Metals acquisition integration, and favorable steel prices.

Zacks Investment Research

Revisiting 2 Outperform Microcaps

Zacks highlights two microcap stocks with Outperform ratings that have delivered strong returns. Perma-Pipe International (PPIH) has gained 250% since May 2024, benefiting from Middle East infrastructure and data center expansion, though facing near-term margin pressure from facility ramp-up costs. Friedman Industries (FRD) has returned 120% since December upgrade, demonstrating operational leverage with EBITDA more than doubling despite steel industry cyclicality risks.

Mentions FRD

Zacks Investment Research

Top Stock Reports for Visa, Intuitive Surgical & Williams Companies

Zacks analysts published research on 16 major stocks on September 29, 2026. Visa maintains strong market position in digital payments but faces margin pressure from rising client incentives.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $FRD · 0 threads

Sign in to post on $FRD

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev